HologicHOLX
NASDAQ · USA · Segment 6 of 8 in the Medicine, pharma & life science value chain: Diagnostics
Women's health defines the range here, from molecular diagnostic tests to mammography systems and surgical products.
Diagnostics: Tests, imaging and assays that support clinical decision-making.
Key metrics
Market cap
$17B
Price
—
Today
—
Return YTD
+2.0%
Return 1Y
−3.5%
P/E
31.2
P/S
4.1
P/B
3.2
Data as of 2026-08-25 · updates daily after U.S. close
Theme exposure
In the value chain
Products & services
- Molecular diagnostics
- Mammography systems
- Surgical products
Competitors
- Roche
- Abbott
- Becton Dickinson
Risks
- Declining covid testing
- Competition in imaging
Supply chain
Supplies →
Same segment: Diagnostics
Compare HOLX
See where Hologic sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →